Research article · Mar 2013
EditorialPublished Feb 2013
Nanotechnology for Circulating Tumor Biomarker Analysis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Nanotechnology for Circulating Tumor Biomarker Analysis Circulating biomarkers are essential for cancer diagnosis and progression monitoring. Nowadays, it is commonly accepted and widely highlighted the need to discover tumour markers to enable early diagnosis, prognosis as well as giving insight into pathogenesis and identifying potentially new treatments. In early stage disease, the application of adjuvant chemo- or radio- therapy after surgery depends on the risk of early tumor recurrence and in advanced stage diseases, the choice between aggressive and mild therapies depends on the stratification of patient risk. Once again, prognostic information relative to cancer patients is expected to allow the definition of effective and personalized treatment strategies.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Biomarkers in Drug Development.
Other · Feb 2013
Editor & Editorial Board Members
Editorial · Feb 2013
Whether Circulating miRNAs or miRNA-Carriers Serve as Biomarkers for Acute Myocardial Infarction
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBiomarkers in Drug Development
- SubjectPathology & Lab Medicine
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Giuseppe Toffoli”
- BylineArticles whose byline prints “Matteo Castronovo”
- BylineArticles whose byline prints “Flavio Rizzolio”
